|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C12N 15/52 | (2006.01) |
| C12N 15/70 | (2006.01) | ||
| C12N 1/21 | (2006.01) | ||
| C07K 14/21 | (2006.01) | ||
| A61K 39/104 | (2006.01) |
| (11) | Number of the document | 3131577 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14784210.8 |
| Date of filing the European patent application | 2014-10-13 | |
| (97) | Date of publication of the European application | 2017-02-22 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-22 |
| (46) | Date of publication of the claims translation | 2020-07-27 |
| (86) | Number | PCT/EP2014/071898 |
| Date | 2014-10-13 |
| (87) | Number | WO 2015/158403 |
| Date | 2015-10-22 |
| (30) | Number | Date | Country code |
| 201461980988 P | 2014-04-17 | US |
| (72) |
KOWARIK, Michael, CH
KEMMLER, Stefan J., CH
QUÉBATTE, Julien L., CH
FERON, Christiane Marie-Paule Simone Jeanne, BE
|
| (73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Modifikuotos ląstelės-šeimininkės ir jų naudojimas |
| MODIFIED HOST CELLS AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2023-09-20 | 10 | 231.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-10-13 |